Does Mounjaro actually reduce a double chin? What the data shows

What did @lauraj19933 actually say?

The video is light on specifics. The transcript is essentially one repeated lyric: "I took the drugs and the drugs are working." Paired with the caption claiming Mounjaro is "reducing chins week by week," the core assertion is simple: tirzepatide is visibly changing her body composition, particularly around the face and jaw area. There is also a referral code for a third-party supplier, MEDEXPRESS, embedded in the caption.

To be clear about what she did not say: she made no clinical claims, cited no doses, and did not describe a mechanism. The content is personal testimony, not medical advice. But personal testimony with a discount code attached is also, functionally, advertising, and that context matters when assessing how viewers are likely to interpret it.

Does the science back this up?

On the basic claim that tirzepatide drives weight loss? Yes, the evidence is strong. On facial fat reduction specifically? That is harder to pin down, but not implausible.

The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) found that tirzepatide at 15mg produced a mean body weight reduction of 20.9% over 72 weeks in adults with obesity. That is a substantial total body fat reduction. When total body fat decreases significantly, facial adipose tissue, including submental fat, commonly referred to as a "double chin," tends to decrease alongside it. This is not unique to tirzepatide. It is a consequence of significant caloric deficit and fat mobilisation regardless of mechanism.

What tirzepatide does differently is activate both GIP and GLP-1 receptors simultaneously, which appears to drive greater weight loss than GLP-1 agonists alone (Frías et al., 2021, New England Journal of Medicine). So "the drugs are working" in this video is consistent with a large and well-powered body of trial evidence.

What did they get wrong (or right)?

She got the core outcome right: tirzepatide does produce meaningful, visible weight loss for many users. Credit where it is due.

What is missing is any acknowledgment of the conditions under which it works. Clinical trials do not show Mounjaro working uniformly for everyone. Responder analyses in SURMOUNT-1 showed meaningful variation. Some participants lost over 25% of body weight; others lost far less. Presenting personal results as a de facto outcome, especially in a short-form video with a referral code attached, strips out that variability entirely.

The referral code arrangement also raises a flag. The UK Medicines and Healthcare products Regulatory Agency (MHRA) and the Advertising Standards Authority (ASA) have both issued guidance indicating that promoting prescription-only medicines directly to consumers is not permitted under UK law. Tirzepatide is a prescription-only medicine in the UK. Whether this video crosses that line legally is a matter for regulators, but ethically, it presents a one-sided picture of a prescription drug to drive commercial referrals.

What should you actually know?

Tirzepatide is one of the most effective pharmacological weight loss agents currently available. That is not hype, it is what the trial data shows. But effective does not mean universally safe, side-effect-free, or appropriate for everyone.

Common adverse effects documented in trials include nausea, vomiting, diarrhoea, and constipation, particularly during dose escalation phases. The SURMOUNT-1 trial reported that 4.3% of participants discontinued due to gastrointestinal side effects. Rarer but more serious concerns include potential associations with thyroid C-cell tumours observed in rodent studies, though human relevance remains under investigation.

In the UK, Mounjaro should be prescribed following clinical assessment, not ordered via referral code. Platforms that operate without full prescriber oversight or that use influencer codes to drive orders should be approached with caution. A legitimate telehealth provider will conduct a structured consultation, review contraindications, and monitor your progress. That process exists for a reason, and a TikTok caption bypasses all of it.